インシュリン様成長因子1受容体の世界市場（～2026年）

• 英文タイトル：Global Insulin Like Growth Factor 1 Receptor Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY01755 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はインシュリン様成長因子1受容体のグローバル市場について調査・分析したレポートです。種類別（BI-893923、CT-707、1R-E1、ATL-1101、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インシュリン様成長因子1受容体の競争状況、市場シェア ・世界のインシュリン様成長因子1受容体市場：種類別市場規模 2015年-2020年（BI-893923、CT-707、1R-E1、ATL-1101、その他） ・世界のインシュリン様成長因子1受容体市場：種類別市場規模予測 2021年-2026年（BI-893923、CT-707、1R-E1、ATL-1101、その他） ・世界のインシュリン様成長因子1受容体市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のインシュリン様成長因子1受容体市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のインシュリン様成長因子1受容体市場分析：米国、カナダ ・ヨーロッパのインシュリン様成長因子1受容体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインシュリン様成長因子1受容体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインシュリン様成長因子1受容体市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインシュリン様成長因子1受容体市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astellas Pharma Inc.、AstraZeneca Plc、Axelar AB、Boehringer Ingelheim GmbH、Bristol-Myers Squibb Company、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、Genmab A/S、Immunomedics, Inc.、Insmed Incorporated、Merck & Co., Inc.、Merrimack Pharmaceuticals, Inc.、Novartis AG、PharmAbcine, Inc.、ProteoThera, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Insulin Like Growth Factor 1 Receptor Market
The global Insulin Like Growth Factor 1 Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Insulin Like Growth Factor 1 Receptor Scope and Market Size
Insulin Like Growth Factor 1 Receptor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Like Growth Factor 1 Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Insulin Like Growth Factor 1 Receptor market is segmented into
BI-893923
CT-707
1R-E1
ATL-1101
Others

Segment by Application, the Insulin Like Growth Factor 1 Receptor market is segmented into
Hospital
Clinic
Others

Regional and Country-level Analysis
The Insulin Like Growth Factor 1 Receptor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Insulin Like Growth Factor 1 Receptor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Insulin Like Growth Factor 1 Receptor Market Share Analysis
Insulin Like Growth Factor 1 Receptor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insulin Like Growth Factor 1 Receptor business, the date to enter into the Insulin Like Growth Factor 1 Receptor market, Insulin Like Growth Factor 1 Receptor product introduction, recent developments, etc.

The major vendors covered:
Astellas Pharma Inc.
AstraZeneca Plc
Axelar AB
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Genmab A/S
Immunomedics, Inc.
Insmed Incorporated
Merck & Co., Inc.
Merrimack Pharmaceuticals, Inc.
Novartis AG
PharmAbcine, Inc.
ProteoThera, Inc.

レポート目次

---

1 Study Coverage
1.1 Insulin Like Growth Factor 1 Receptor Product Introduction
1.2 Market Segments
1.3 Key Insulin Like Growth Factor 1 Receptor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Insulin Like Growth Factor 1 Receptor Market Size Growth Rate by Type
1.4.2 BI-893923
1.4.3 CT-707
1.4.4 1R-E1
1.4.5 ATL-1101
1.4.6 Others
1.5 Market by Application
1.5.1 Global Insulin Like Growth Factor 1 Receptor Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Insulin Like Growth Factor 1 Receptor Market Size, Estimates and Forecasts
2.1.1 Global Insulin Like Growth Factor 1 Receptor Revenue 2015-2026
2.1.2 Global Insulin Like Growth Factor 1 Receptor Sales 2015-2026
2.2 Global Insulin Like Growth Factor 1 Receptor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Insulin Like Growth Factor 1 Receptor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Insulin Like Growth Factor 1 Receptor Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Insulin Like Growth Factor 1 Receptor Competitor Landscape by Players
3.1 Insulin Like Growth Factor 1 Receptor Sales by Manufacturers
3.1.1 Insulin Like Growth Factor 1 Receptor Sales by Manufacturers (2015-2020)
3.1.2 Insulin Like Growth Factor 1 Receptor Sales Market Share by Manufacturers (2015-2020)
3.2 Insulin Like Growth Factor 1 Receptor Revenue by Manufacturers
3.2.1 Insulin Like Growth Factor 1 Receptor Revenue by Manufacturers (2015-2020)
3.2.2 Insulin Like Growth Factor 1 Receptor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Insulin Like Growth Factor 1 Receptor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Insulin Like Growth Factor 1 Receptor Revenue in 2019
3.2.5 Global Insulin Like Growth Factor 1 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Insulin Like Growth Factor 1 Receptor Price by Manufacturers
3.4 Insulin Like Growth Factor 1 Receptor Manufacturing Base Distribution, Product Types
3.4.1 Insulin Like Growth Factor 1 Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insulin Like Growth Factor 1 Receptor Product Type
3.4.3 Date of International Manufacturers Enter into Insulin Like Growth Factor 1 Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Insulin Like Growth Factor 1 Receptor Market Size by Type (2015-2020)
4.1.1 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2015-2020)
4.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2015-2020)
4.1.3 Insulin Like Growth Factor 1 Receptor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Insulin Like Growth Factor 1 Receptor Market Size Forecast by Type (2021-2026)
4.2.1 Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Type (2021-2026)
4.2.2 Global Insulin Like Growth Factor 1 Receptor Revenue Forecast by Type (2021-2026)
4.2.3 Insulin Like Growth Factor 1 Receptor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Insulin Like Growth Factor 1 Receptor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Insulin Like Growth Factor 1 Receptor Market Size by Application (2015-2020)
5.1.1 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2015-2020)
5.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2015-2020)
5.1.3 Insulin Like Growth Factor 1 Receptor Price by Application (2015-2020)
5.2 Insulin Like Growth Factor 1 Receptor Market Size Forecast by Application (2021-2026)
5.2.1 Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Application (2021-2026)
5.2.2 Global Insulin Like Growth Factor 1 Receptor Revenue Forecast by Application (2021-2026)
5.2.3 Global Insulin Like Growth Factor 1 Receptor Price Forecast by Application (2021-2026)

6 North America
6.1 North America Insulin Like Growth Factor 1 Receptor by Country
6.1.1 North America Insulin Like Growth Factor 1 Receptor Sales by Country
6.1.2 North America Insulin Like Growth Factor 1 Receptor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Type
6.3 North America Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Application

7 Europe
7.1 Europe Insulin Like Growth Factor 1 Receptor by Country
7.1.1 Europe Insulin Like Growth Factor 1 Receptor Sales by Country
7.1.2 Europe Insulin Like Growth Factor 1 Receptor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Type
7.3 Europe Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Insulin Like Growth Factor 1 Receptor by Region
8.1.1 Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Region
8.1.2 Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Type
8.3 Asia Pacific Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Application

9 Latin America
9.1 Latin America Insulin Like Growth Factor 1 Receptor by Country
9.1.1 Latin America Insulin Like Growth Factor 1 Receptor Sales by Country
9.1.2 Latin America Insulin Like Growth Factor 1 Receptor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Type
9.3 Central & South America Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Insulin Like Growth Factor 1 Receptor by Country
10.1.1 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country
10.1.2 Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Type
10.3 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Application

11 Company Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Description and Business Overview
11.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Products Offered
11.1.5 Astellas Pharma Inc. Related Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Corporation Information
11.2.2 AstraZeneca Plc Description and Business Overview
11.2.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Products Offered
11.2.5 AstraZeneca Plc Related Developments
11.3 Axelar AB
11.3.1 Axelar AB Corporation Information
11.3.2 Axelar AB Description and Business Overview
11.3.3 Axelar AB Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Axelar AB Insulin Like Growth Factor 1 Receptor Products Offered
11.3.5 Axelar AB Related Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Corporation Information
11.4.2 Boehringer Ingelheim GmbH Description and Business Overview
11.4.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Products Offered
11.4.5 Boehringer Ingelheim GmbH Related Developments
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Corporation Information
11.5.2 Bristol-Myers Squibb Company Description and Business Overview
11.5.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Products Offered
11.5.5 Bristol-Myers Squibb Company Related Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Corporation Information
11.6.2 Eli Lilly and Company Description and Business Overview
11.6.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Products Offered
11.6.5 Eli Lilly and Company Related Developments
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.7.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
11.7.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Products Offered
11.7.5 F. Hoffmann-La Roche Ltd. Related Developments
11.8 Genmab A/S
11.8.1 Genmab A/S Corporation Information
11.8.2 Genmab A/S Description and Business Overview
11.8.3 Genmab A/S Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Genmab A/S Insulin Like Growth Factor 1 Receptor Products Offered
11.8.5 Genmab A/S Related Developments
11.9 Immunomedics, Inc.
11.9.1 Immunomedics, Inc. Corporation Information
11.9.2 Immunomedics, Inc. Description and Business Overview
11.9.3 Immunomedics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Products Offered
11.9.5 Immunomedics, Inc. Related Developments
11.10 Insmed Incorporated
11.10.1 Insmed Incorporated Corporation Information
11.10.2 Insmed Incorporated Description and Business Overview
11.10.3 Insmed Incorporated Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Products Offered
11.10.5 Insmed Incorporated Related Developments
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Description and Business Overview
11.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Products Offered
11.1.5 Astellas Pharma Inc. Related Developments
11.12 Merrimack Pharmaceuticals, Inc.
11.12.1 Merrimack Pharmaceuticals, Inc. Corporation Information
11.12.2 Merrimack Pharmaceuticals, Inc. Description and Business Overview
11.12.3 Merrimack Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Merrimack Pharmaceuticals, Inc. Products Offered
11.12.5 Merrimack Pharmaceuticals, Inc. Related Developments
11.13 Novartis AG
11.13.1 Novartis AG Corporation Information
11.13.2 Novartis AG Description and Business Overview
11.13.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Novartis AG Products Offered
11.13.5 Novartis AG Related Developments
11.14 PharmAbcine, Inc.
11.14.1 PharmAbcine, Inc. Corporation Information
11.14.2 PharmAbcine, Inc. Description and Business Overview
11.14.3 PharmAbcine, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.14.4 PharmAbcine, Inc. Products Offered
11.14.5 PharmAbcine, Inc. Related Developments
11.15 ProteoThera, Inc.
11.15.1 ProteoThera, Inc. Corporation Information
11.15.2 ProteoThera, Inc. Description and Business Overview
11.15.3 ProteoThera, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.15.4 ProteoThera, Inc. Products Offered
11.15.5 ProteoThera, Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Insulin Like Growth Factor 1 Receptor Market Estimates and Projections by Region
12.1.1 Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Regions 2021-2026
12.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue Forecast by Regions 2021-2026
12.2 North America Insulin Like Growth Factor 1 Receptor Market Size Forecast (2021-2026)
12.2.1 North America: Insulin Like Growth Factor 1 Receptor Sales Forecast (2021-2026)
12.2.2 North America: Insulin Like Growth Factor 1 Receptor Revenue Forecast (2021-2026)
12.2.3 North America: Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2021-2026)
12.3 Europe Insulin Like Growth Factor 1 Receptor Market Size Forecast (2021-2026)
12.3.1 Europe: Insulin Like Growth Factor 1 Receptor Sales Forecast (2021-2026)
12.3.2 Europe: Insulin Like Growth Factor 1 Receptor Revenue Forecast (2021-2026)
12.3.3 Europe: Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Insulin Like Growth Factor 1 Receptor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Insulin Like Growth Factor 1 Receptor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Insulin Like Growth Factor 1 Receptor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Insulin Like Growth Factor 1 Receptor Market Size Forecast by Region (2021-2026)
12.5 Latin America Insulin Like Growth Factor 1 Receptor Market Size Forecast (2021-2026)
12.5.1 Latin America: Insulin Like Growth Factor 1 Receptor Sales Forecast (2021-2026)
12.5.2 Latin America: Insulin Like Growth Factor 1 Receptor Revenue Forecast (2021-2026)
12.5.3 Latin America: Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Insulin Like Growth Factor 1 Receptor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Insulin Like Growth Factor 1 Receptor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Insulin Like Growth Factor 1 Receptor Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insulin Like Growth Factor 1 Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Insulin Like Growth Factor 1 Receptor Market Segments
Table 2. Ranking of Global Top Insulin Like Growth Factor 1 Receptor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Like Growth Factor 1 Receptor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of BI-893923
Table 5. Major Manufacturers of CT-707
Table 6. Major Manufacturers of 1R-E1
Table 7. Major Manufacturers of ATL-1101
Table 8. Major Manufacturers of Others
Table 9. Global Insulin Like Growth Factor 1 Receptor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Insulin Like Growth Factor 1 Receptor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Insulin Like Growth Factor 1 Receptor Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Regions (2015-2020)
Table 13. Global Insulin Like Growth Factor 1 Receptor Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Insulin Like Growth Factor 1 Receptor Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Insulin Like Growth Factor 1 Receptor Sales Share by Manufacturers (2015-2020)
Table 16. Global Insulin Like Growth Factor 1 Receptor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Insulin Like Growth Factor 1 Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Like Growth Factor 1 Receptor as of 2019)
Table 18. Insulin Like Growth Factor 1 Receptor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Insulin Like Growth Factor 1 Receptor Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Insulin Like Growth Factor 1 Receptor Price (2015-2020) (USD/Pcs)
Table 21. Insulin Like Growth Factor 1 Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Insulin Like Growth Factor 1 Receptor Product Type
Table 23. Date of International Manufacturers Enter into Insulin Like Growth Factor 1 Receptor Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 26. Global Insulin Like Growth Factor 1 Receptor Sales Share by Type (2015-2020)
Table 27. Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Insulin Like Growth Factor 1 Receptor Revenue Share by Type (2015-2020)
Table 29. Insulin Like Growth Factor 1 Receptor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 31. Global Insulin Like Growth Factor 1 Receptor Sales Share by Application (2015-2020)
Table 32. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2015-2020) (K Pcs)
Table 33. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2015-2020)
Table 34. North America Insulin Like Growth Factor 1 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2015-2020)
Table 36. North America Insulin Like Growth Factor 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 37. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2015-2020)
Table 38. North America Insulin Like Growth Factor 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 39. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2015-2020)
Table 40. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2015-2020)
Table 42. Europe Insulin Like Growth Factor 1 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2015-2020)
Table 44. Europe Insulin Like Growth Factor 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2015-2020)
Table 46. Europe Insulin Like Growth Factor 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2015-2020)
Table 56. Latin America Insulin Like Growth Factor 1 Receptor Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Insulin Like Growth Factor 1 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2015-2020)
Table 60. Latin America Insulin Like Growth Factor 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2015-2020)
Table 62. Latin America Insulin Like Growth Factor 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2015-2020)
Table 72. Astellas Pharma Inc. Corporation Information
Table 73. Astellas Pharma Inc. Description and Major Businesses
Table 74. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Astellas Pharma Inc. Product
Table 76. Astellas Pharma Inc. Recent Development
Table 77. AstraZeneca Plc Corporation Information
Table 78. AstraZeneca Plc Description and Major Businesses
Table 79. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AstraZeneca Plc Product
Table 81. AstraZeneca Plc Recent Development
Table 82. Axelar AB Corporation Information
Table 83. Axelar AB Description and Major Businesses
Table 84. Axelar AB Insulin Like Growth Factor 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Axelar AB Product
Table 86. Axelar AB Recent Development
Table 87. Boehringer Ingelheim GmbH Corporation Information
Table 88. Boehringer Ingelheim GmbH Description and Major Businesses
Table 89. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Boehringer Ingelheim GmbH Product
Table 91. Boehringer Ingelheim GmbH Recent Development
Table 92. Bristol-Myers Squibb Company Corporation Information
Table 93. Bristol-Myers Squibb Company Description and Major Businesses
Table 94. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Bristol-Myers Squibb Company Product
Table 96. Bristol-Myers Squibb Company Recent Development
Table 97. Eli Lilly and Company Corporation Information
Table 98. Eli Lilly and Company Description and Major Businesses
Table 99. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Eli Lilly and Company Product
Table 101. Eli Lilly and Company Recent Development
Table 102. F. Hoffmann-La Roche Ltd. Corporation Information
Table 103. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 104. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. F. Hoffmann-La Roche Ltd. Product
Table 106. F. Hoffmann-La Roche Ltd. Recent Development
Table 107. Genmab A/S Corporation Information
Table 108. Genmab A/S Description and Major Businesses
Table 109. Genmab A/S Insulin Like Growth Factor 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Genmab A/S Product
Table 111. Genmab A/S Recent Development
Table 112. Immunomedics, Inc. Corporation Information
Table 113. Immunomedics, Inc. Description and Major Businesses
Table 114. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Immunomedics, Inc. Product
Table 116. Immunomedics, Inc. Recent Development
Table 117. Insmed Incorporated Corporation Information
Table 118. Insmed Incorporated Description and Major Businesses
Table 119. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Insmed Incorporated Product
Table 121. Insmed Incorporated Recent Development
Table 122. Merck & Co., Inc. Corporation Information
Table 123. Merck & Co., Inc. Description and Major Businesses
Table 124. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Merck & Co., Inc. Product
Table 126. Merck & Co., Inc. Recent Development
Table 127. Merrimack Pharmaceuticals, Inc. Corporation Information
Table 128. Merrimack Pharmaceuticals, Inc. Description and Major Businesses
Table 129. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Merrimack Pharmaceuticals, Inc. Product
Table 131. Merrimack Pharmaceuticals, Inc. Recent Development
Table 132. Novartis AG Corporation Information
Table 133. Novartis AG Description and Major Businesses
Table 134. Novartis AG Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. Novartis AG Product
Table 136. Novartis AG Recent Development
Table 137. PharmAbcine, Inc. Corporation Information
Table 138. PharmAbcine, Inc. Description and Major Businesses
Table 139. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. PharmAbcine, Inc. Product
Table 141. PharmAbcine, Inc. Recent Development
Table 142. ProteoThera, Inc. Corporation Information
Table 143. ProteoThera, Inc. Description and Major Businesses
Table 144. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. ProteoThera, Inc. Product
Table 146. ProteoThera, Inc. Recent Development
Table 147. Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 148. Global Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Regions (2021-2026)
Table 149. Global Insulin Like Growth Factor 1 Receptor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 150. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share Forecast by Regions (2021-2026)
Table 151. North America: Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 152. North America: Insulin Like Growth Factor 1 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Europe: Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 154. Europe: Insulin Like Growth Factor 1 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Asia Pacific: Insulin Like Growth Factor 1 Receptor Sales Forecast by Region (2021-2026) (K Pcs)
Table 156. Asia Pacific: Insulin Like Growth Factor 1 Receptor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 157. Latin America: Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 158. Latin America: Insulin Like Growth Factor 1 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Middle East and Africa: Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 160. Middle East and Africa: Insulin Like Growth Factor 1 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 161. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 162. Key Challenges
Table 163. Market Risks
Table 164. Main Points Interviewed from Key Insulin Like Growth Factor 1 Receptor Players
Table 165. Insulin Like Growth Factor 1 Receptor Customers List
Table 166. Insulin Like Growth Factor 1 Receptor Distributors List
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Like Growth Factor 1 Receptor Product Picture
Figure 2. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type in 2020 & 2026
Figure 3. BI-893923 Product Picture
Figure 4. CT-707 Product Picture
Figure 5. 1R-E1 Product Picture
Figure 6. ATL-1101 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Insulin Like Growth Factor 1 Receptor Report Years Considered
Figure 13. Global Insulin Like Growth Factor 1 Receptor Market Size 2015-2026 (US$ Million)
Figure 14. Global Insulin Like Growth Factor 1 Receptor Sales 2015-2026 (K Pcs)
Figure 15. Global Insulin Like Growth Factor 1 Receptor Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2015-2020)
Figure 17. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region in 2019
Figure 18. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2015-2020)
Figure 19. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region in 2019
Figure 20. Global Insulin Like Growth Factor 1 Receptor Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Insulin Like Growth Factor 1 Receptor Revenue in 2019
Figure 22. Insulin Like Growth Factor 1 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2015-2020)
Figure 24. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type in 2019
Figure 25. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2015-2020)
Figure 26. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type in 2019
Figure 27. Global Insulin Like Growth Factor 1 Receptor Market Share by Price Range (2015-2020)
Figure 28. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2015-2020)
Figure 29. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application in 2019
Figure 30. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2015-2020)
Figure 31. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application in 2019
Figure 32. North America Insulin Like Growth Factor 1 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Insulin Like Growth Factor 1 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country in 2019
Figure 35. North America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country in 2019
Figure 36. U.S. Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Insulin Like Growth Factor 1 Receptor Market Share by Type in 2019
Figure 41. North America Insulin Like Growth Factor 1 Receptor Market Share by Application in 2019
Figure 42. Europe Insulin Like Growth Factor 1 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Insulin Like Growth Factor 1 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Country in 2019
Figure 45. Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country in 2019
Figure 46. Germany Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Insulin Like Growth Factor 1 Receptor Market Share by Type in 2019
Figure 57. Europe Insulin Like Growth Factor 1 Receptor Market Share by Application in 2019
Figure 58. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Region in 2019
Figure 61. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region in 2019
Figure 62. China Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Insulin Like Growth Factor 1 Receptor Market Share by Type in 2019
Figure 85. Asia Pacific Insulin Like Growth Factor 1 Receptor Market Share by Application in 2019
Figure 86. Latin America Insulin Like Growth Factor 1 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Insulin Like Growth Factor 1 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country in 2019
Figure 89. Latin America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country in 2019
Figure 90. Mexico Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Insulin Like Growth Factor 1 Receptor Market Share by Type in 2019
Figure 97. Latin America Insulin Like Growth Factor 1 Receptor Market Share by Application in 2019
Figure 98. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country in 2019
Figure 102. Turkey Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Share by Type in 2019
Figure 109. Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Share by Application in 2019
Figure 110. North America Insulin Like Growth Factor 1 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Insulin Like Growth Factor 1 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Insulin Like Growth Factor 1 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Insulin Like Growth Factor 1 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Insulin Like Growth Factor 1 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Insulin Like Growth Factor 1 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

---